KIMBERLY SADRI: Open Payments
NPI 1750893277 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 27 payments from 11 companies in 2025. Trend: 2023 $444 · 2024 $772 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Amgen Inc. | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $30 |
| Philips North America LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: LEQVIO, LifeVest, JARDIANCE, Kerendia, ONPATTRO, REPATHA, SAPIEN 3 Ultra RESILIA, Ambulatory Monitoring & Diagnostics Undivided.
Industry payments across SC — which companies pay providers there.
